Drug Database
FI

filgrastim (long-acting)

✓ Approved

Win Medica · CSF3R · 重组蛋白

什么是 filgrastim (long-acting)?

filgrastim (long-acting) 是一种重组蛋白,由Win Medica研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

公司Win Medica
药物类别重组蛋白
分子靶点CSF3R
给药途径Unknown
状态Approved

作用机制

分子靶点

filgrastim (long-acting) 作用于 1 个分子靶点:

CSF3Rcolony stimulating factor 3 receptor (CD114, GCSFR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

filgrastim (long-acting) 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Blood and lymphatic system disordersBone marrow disorder✓ Approved

相关研究文献

PubMedJournal of the American Chemical Society2026-11-19

Supramolecular Polymer Nanoparticles for Polymer Toughening.

Sheng Lan L, He Zejian Z, Chen Liya L, Pan Yuling Y et al.

Nanoparticle toughening of polymers has long been constrained by the inherent trade-off between strength and toughness. Here, we report a supramolecular polymer nanoparticle toughening strategy based on an H2G2-type monomer (H2G2-1). During epoxy curing, H2G2-1 undergoes in situ self-assembly into supramolecular polymer nanoparticles (H2G2-NPs), which serve dual roles: acting as physical cross-linking points for reinforcement, while their reversible host-guest interactions function as sacrificial bonds that dissociate under stress to dissipate energy. This strategy ensures uniform nanoparticle dispersion and excellent interfacial compatibility. Compared to neat epoxy, the H2G2-NPs-toughened epoxy exhibits a 92.6% increase in elongation at break, a 66.0% increase in tensile strength, and a 233% increase in toughness, achieving synergistic strengthening and toughening. This work provides a new strategy to make high-performance toughened polymers.

PMID 43053378
阅读全文 →
PubMedBMC medicine2026-11-19

Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants.

Shakhshir Lama A LA, Pell Jill P JP, Hastie Claire E CE, Nelson Scott M SM et al.

Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes. A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score. Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07-1.19), VSGA (aOR 1.14, 95% CI 1.03-1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01-1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01-1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73-0.89). No associations were observed with stillbirth. The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.

PMID 43053014
阅读全文 →
PubMedCell death & disease2026-11-19

The role of SAM-dependent internal m7G modification of LINC01252 in the progression of hepatocellular carcinoma.

Zhao Xuehan X, Shi Min M, Zhao Li L, Jiang Yingying Y et al.

Dysregulation of long non-coding RNAs (lncRNAs) plays a significant role in the progression of hepatocellular carcinoma (HCC), yet many underlying mechanisms remain elusive. Recent studies have highlighted the critical importance of internal N7-methylguanosine (m7G) modifications in influencing RNA expression and function. In this study, we identified LINC01252, a poorly characterized lncRNA, through analyses of GEO datasets and the TCGA cohort. Notably, LINC01252 is downregulated in HCC tissues and is associated with prognostic outcomes, although the predictive value of a nomogram based on LINC01252 expression characteristics appears to be limited. Our results indicate that LINC01252 effectively inhibits tumorigenic behaviors in HCC and exerts its effects by targeting the oncogene NUPR1. Mechanistically, LINC01252 acts as an intranuclear lncRNA that binds to the NUPR1 promoter through Hoogsteen pairing, consequently inhibiting its transcriptional activity. Additionally, the internal m7G modification level of LINC01252 directly influences its RNA stability, contingent upon sufficient concentrations of S-adenosylmethionine (SAM), which is necessary for the activity of its key modifying enzymes, METTL1 and WDR4. Thus, LINC01252's m7G modification and expression are SAM-dependent in the context of HCC. Furthermore, LINC01252 can also suppress WDR4 transcription by binding to its promoter through the same mechanism, thus inhibiting HCC progression. Our findings suggest that LINC01252 functions as a SAM-dependent, m7G-related lncRNA, acting as a transcriptional repressor of NUPR1 and WDR4, while establishing a negative feedback loop between LINC01252 and WDR4. However, the potential of LINC01252 as a clinical biomarker still requires further investigation.

PMID 43052238
阅读全文 →
PubMedBMC plant biology2026-11-19

Genome-wide identification and expression pattern analysis of the Medicago sativa 4-coumarate: CoA ligase (4CL) gene family.

Lei Haiyue H, Liu Shuyan S, Zhang Yuqi Y, Ma Xinyue X et al.

4-Coumarate: CoA ligase (4CL) is a pivotal enzyme in the phenylpropanoid metabolic pathway and plays a crucial role in plant growth, development, and stress responses. In this study, a genome-wide analysis was conducted to identify a total of 43 Ms4CL genes (Ms4CLs) in 'Xinjiangdaye' (Medicago sativa). The fundamental structure, phylogenetic relationships, cis-acting element analysis, and expression patterns of these genes were systematically analysed. The results indicate that Ms4CL genes can be classified into five subfamilies, and subcellular localization predictions suggest that most genes are localized to the plasma membrane. The number of exons ranges from four to thirteen, consistent with the characteristics of most 4CL gene families. The promoter regions are rich in stress response elements associated with MeJA, ABA, and drought, implying that the expression of these genes may be regulated by stress-induced hormonal signals. Collinearity analyses revealed that segmental duplications contributed substantially to the expansion of this family. Analysis of tissue-specific expression revealed that the four genes Ms4CL8, Ms4CL22, Ms4CL37, and Ms4CL42 exhibit tissue-specific expression patterns. An analysis of responses to abiotic stresses indicates that Ms4CL5 and Ms4CL13 are stress-induced genes in response to salt and drought stresses, whereas Ms4CL3 is a stress-repressed gene in response to salt and drought stresses. These three genes exhibit distinct functional differentiation in stress responses. Cis-acting element analysis further revealed promoter enrichment in defense/stress-responsive and phytohormone-related elements, consistent with their roles in environmental adaptation. This study provides a theoretical foundation for elucidating the mechanisms of salt and drought tolerance in alfalfa and supports its genetic improvement.

PMID 43052703
阅读全文 →
PubMedCommunications biology2026-11-19

Microbes and diet reshape the Drosophila intestine via distinct cellular dynamics.

Bonfini Alessandro A, Buchon Nicolas N

The intestine adapts to environmental challenges by changing size, but whether such remodeling reflects fixed homeostatic restoration or context-dependent adaptation remains unclear. Here, using Drosophila melanogaster, we combine defined diets with oral bacterial infection to quantify midgut size, cell number, cell size, and epithelial turnover. We show that diet and infection reshape the midgut through distinct cellular programs. Infection causes rapid shrinkage only when the organ was initially large, whereas post-infection regrowth requires dietary nutrients and converges toward a diet-defined state rather than a fixed pre-injury size. Diet-driven expansion occurs primarily through enterocyte hypertrophy and persists after stem cell ablation, whereas infection-induced recovery requires intestinal stem cell/progenitor activity. Microbes also have context-dependent effects, acting as damaging stressors in nutrient-rich conditions but promoting growth and survival under nutrient-poor conditions. These findings reveal modular cellular strategies through which diet and microbes jointly shape epithelial plasticity.

PMID 43052374
阅读全文 →
PubMedBMC infectious diseases2026-11-19

Comparative analysis of SNPs associated with COVID-19 and chronic liver disease identifies DPP9 as a candidate genetic marker for Long COVID.

da Silva Lucas Lima LL, Maya-Miles Douglas D, Maul Juliana Cardoso JC, Paulo Iolanda Raquel Ferreira IRF et al.

Long COVID is a multisystemic condition characterized by persistent symptoms after acute SARS-CoV-2 infection, whose biological mechanisms are not yet fully understood. Host genetic factors may be associated, and the sharing of genetic architecture with other chronic diseases such as viral hepatitis B and C may aid in understanding this disease. A cross-sectional study was conducted including 150 individuals stratified into two groups: (i) Long COVID and (ii) chronic viral hepatitis B and C. Eighteen single nucleotide polymorphisms (SNPs) previously associated with COVID-19 severity and inflammatory pathways were genotyped using TaqMan® real-time PCR assays. The analyses of genetic association models were performed using multivariate logistic regression adjusted for gender, self-reported skin color, and comorbidities. Mental health scales for assessing depression (Beck), anxiety (Hamilton), fatigue, and post-COVID functional scale were used both to define the syndrome and for subsequent analyses of the genotypic profile probably associated with Long COVID. Among all the SNPs analyzed, rs12610495 (A/G) in the DPP9 gene was the only variant consistently associated with Long COVID. After adjustment for sex, self-reported skin color, and hepatitis status, carriers of the G variant allele demonstrated increased odds of Long COVID under the dominant model (OR = 2.66; 95% CI: 1.08-6.57; p = 0.029) and the overdominant model (OR = 2.96; 95% CI: 1.17-7.52; p = 0.018). The association was more pronounced in women (OR = 3.30; 95% CI: 1.08-10.07). Exploratory analyses of mental and functional outcomes did not reach statistical significance, although a higher frequency of functional limitation and fatigue was observed among carriers of the G allele. This study suggests that DPP9 rs12610495 is associated with Long COVID, previously associated only with severe acute COVID, demonstrating that individuals carrying the rs12610495 G variant allele had higher odds of developing Long COVID. The inclusion of viral hepatitis as a chronic inflammatory condition for comparison contributed to the identification of shared genetic archetypal among diseases, revealing the possible role of DPP9 with Long COVID and highlighting this gene as a relevant target for future validation studies.

PMID 43052846
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多filgrastim (long-acting)